ACR/ARHP 2013 Report – Early and aggressive DMARD treatment improves outcomes in psoriatic arthritis
Treatment of psoriatic arthritis with early, aggressive pharmacologic intervention with disease-modifying antirheumatic drugs (DMARDs) while utilizing a a treat-to-target approach achieves better outcomes than standard care, researchers reported … read more.